Duncan Gregory Scott
SEC insider (Form 3/4/5 filer). CIK 0001831127. CHIEF EXECUTIVE OFFICER at Dogwood Therapeutics, Inc. (DWTX) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Mar 5, 2026. Located in ALPHARETTA, GA.
Companies Duncan Gregory Scott has filed insider reports for
- Dogwood Therapeutics, Inc. (DWTX): Director, Officer, CHIEF EXECUTIVE OFFICER
- CorMedix Inc. (CRMD): Director
Duncan Gregory Scott
CIK: 0001831127
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 5, 2026DWTX
Dogwood Therapeutics, Inc.
AwardDirectStock Option (right to buy)
330K shares- - Jan 26, 2026CRMD
CorMedix Inc.
AwardDirect30.5K shares- - Dec 4, 2025DWTX
Dogwood Therapeutics, Inc.
AwardDirectStock Option (right to buy)
460K shares- - Sep 16, 2025CRMD
CorMedix Inc.
ExerciseDirect13.3K shares at avg. $8.32$111K - Jun 27, 2025DWTX
Dogwood Therapeutics, Inc.
AwardDirectStock Option (right to buy)
40K shares- - Jan 17, 2025CRMD
CorMedix Inc.
AwardDirect25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 5, 2026 |  DWTX Dogwood Therapeutics, Inc. | Award Stock Option (right to buy) | 330,000 | - | - | Direct |
| Jan 26, 2026 |  CRMD CorMedix Inc. | Award | 30,453 | - | $0 | Direct |
| Dec 4, 2025 | DWTX Dogwood Therapeutics, Inc. | Award Stock Option (right to buy) | 460,000 | - | - | Direct |
| Sep 16, 2025 | CRMD CorMedix Inc. | Exercise | 13,333 | $8.32 | $110,931 | Direct |
| Jun 27, 2025 | DWTX Dogwood Therapeutics, Inc. | Award Stock Option (right to buy) | 40,000 | - | - | Direct |
| Jan 17, 2025 | CRMD CorMedix Inc. | Award | 25,000 | - | $0 | Direct |
1-6 of 6 transactions